KALA BIO, Inc. (KALA) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
KALA Revenue Growth
KALA Revenue Analysis (2013–2024)
As of May 8, 2026, KALA BIO, Inc. (KALA) generated trailing twelve-month (TTM) revenue of $254,000. The most recent quarter (Q3 2025) recorded $0 in revenue.
Looking at the longer-term picture, KALA's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $11.2 million in 2021.
When compared to Healthcare sector peers including OCUL (-12.8% YoY), LNTH (+0.6% YoY), and HROW (+36.4% YoY). Compare KALA vs OCUL →
KALA Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| KALACurrent | $254,000 | - | - | - | |
 OCUL | $52M | -12.8% | +24.4% | -521.0% | |
 LNTH | $1.5B | +0.6% | +35.3% | 20.2% | |
 HROW | $272M | +36.4% | +41.0% | 11.2% | |
 SGHT | $77M | +1.8% | +22.9% | -48.0% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% |
KALA Historical Revenue Data (2013–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $0 | - | $-259,000 | - | $-40,983,000 | - |
| 2023 | $0 | -100.0% | $-303,000 | - | $-39,153,000 | - |
| 2022 | $3.9M | -65.4% | $1.3M | 34.2% | $-81,356,000 | -2090.3% |
| 2021 | $11.2M | +76.7% | $7.1M | 63.5% | $-109,433,000 | -973.6% |
| 2020 | $6.4M | +4.7% | $3.2M | 50.1% | $-96,231,000 | -1512.6% |
| 2019 | $6.1M | - | $4.1M | 66.9% | $-88,224,000 | -1452.5% |
| 2018 | $0 | - | $-955,000 | - | $-64,721,000 | - |
| 2017 | $0 | - | $-643,000 | - | $-39,875,000 | - |
| 2016 | $0 | -100.0% | $-297,000 | - | $-32,669,000 | - |
| 2015 | $45K | -90.1% | $45K | 100.0% | $-15,946,000 | -35435.6% |
See KALA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs KALA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare KALA vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonKALA — Frequently Asked Questions
Quick answers to the most common questions about buying KALA stock.
Is KALA's revenue growth accelerating or slowing?
KALA TTM revenue: $254000.00. YoY growth: N/A. 5-year CAGR: N/A.
What is KALA's long-term revenue growth rate?
KALA BIO, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is KALA's revenue distributed by segment?
KALA reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.